Patients and health care professionals should report any adverse reactions to FDAs MedWatch program: Complete and submit the report online at www.fda.gov/medwatch/report.htm Download and complete the appropriate form, then submit it via fax at 1-800-FDA-0178.
Bydureon BCise side effects Common side effects of Bydureon BCise include: A lump at the injection site Nausea Headache Diarrhea Vomiting Dizziness Constipation Less common but more serious side effects include an allergic reaction, pancreatitis, gallbladder problems, and kidney damage
Cell-based experiments also demonstrate receptor-dependent signaling changes when GLP-RTinteracts with GLP-1R, GIPR, or GCGR expressing cells
It signals the body that muscle is being used and should be maintained
Wegovy Injection: Initial dose (weeks 1 through 4): 0.25 mg subcutaneously once a week Dose escalation: Weeks 5 through 8: 0.5 mg subcutaneously once a week Weeks 9 through 12: 1 mg subcutaneously once a week Weeks 13 through 16: 1.7 mg subcutaneously once a week Alternatively: 1.7 mg subcutaneously once a week Comments: Major adverse cardiovascular (CV) events include CV death, nonfatal myocardial infarction, or nonfatal stroke